Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|November 20, 2008
Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission: long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG)Carmen D Schweighofer, Matthias Ritgen, Barbara F Eichhorst, et al.
Transplantation|December 1, 2017
End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD RegistryHeiner Zimmermann, Timm Denecke, Martin H Dreyling, et al.
Haematologica|May 21, 2009
Identification of the gene encoding cyclin E1 (CCNE1) as a novel IGH translocation partner in t(14;19)(q32;q12) in diffuse large B-cell lymphomaInga Nagel, Takashi Akasaka, Wolfram Klapper, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 16, 2013
Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphomaAnna Czajczynska, Andreas Günther, Roland Repp, et al.
Cancer|April 22, 2011
Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphomaSascha Dietrich, Blanca Tielesch, Michael Rieger, et al.
Blood|October 7, 2006
Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trialsThorsten Raff, Nicola Gökbuget, Silke Lüschen, et al.
Cancer|December 7, 2005
Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphomaNobert Schmitz, Marita Kloess, Marcel Reiser, et al.
Haematologica|April 2, 2008
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinationsSebastian Böttcher, Matthias Ritgen, Sebastian Buske, et al.
Onkologie|December 17, 2008
[Treatment of nonresectable liver metastases]Markus Moehler, Karsten Ridwelski, Meinolf Karthaus, et al.
Blood|May 27, 2006
Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemiaThorsten Zenz, Matthias Ritgen, Peter Dreger, et al.
Pageof 10